Target intelligence / Profile preview

Mitochondrial-processing peptidase subunit alpha (PMPCA)

Target
PMPCA
Molecular classification
Enzyme, Metalloendopeptidase
01

Overview

Mitochondrial-processing peptidase subunit alpha (PMPCA) is the alpha subunit of mitochondrial processing peptidase (MPP), a heterodimeric enzyme located in the mitochondrial matrix that is essential for cleaving the N-terminal transit peptides from nuclear-encoded mitochondrial precursor proteins, thereby enabling their proper folding, import, and maturation[1][2][4]. It forms a functional heterodimer with the beta subunit (PMPCB), which contains the catalytic site, while PMPCA is necessary for substrate recognition and binding[1][2]. Deficiency or mutation in PMPCA impairs mitochondrial protein processing, and is causally linked to a range of neurodegenerative diseases, including autosomal recessive spinocerebellar ataxia and Friedreich ataxia, as well as late-onset dominant optic atrophy[3][4]. PMPCA’s activity is indispensable for cellular viability, especially neuronal health, and altering its function can cause severe mitochondrial dysfunction and neurodegeneration[1][2][3][4].

Other names
Alpha-MPPP-55Inactive zinc metalloprotease alphaMAS2INPP5EMPPACerebellar ataxia-1Spinocerebellar ataxia, autosomal recessive 2CLA1SCAR2KIAA0123CPD3Peptidase (mitochondrial processing) alpha
02

Biological functions

Cleavage of N-terminal presequences from nuclear-encoded mitochondrial precursor proteinsProtein maturation (mitochondrial protein processing)Maintenance of mitochondrial proteome integrityFacilitates mitochondrial protein folding and import
03

Disease associations

Neurodegenerative diseaseCerebellar ataxiaSpinocerebellar ataxiaFriedreich ataxiaOptic atrophy
04

Safety considerations

Loss-of-function or missense mutations disrupt mitochondrial protein maturation and lead to non-progressive cerebellar ataxia, spinocerebellar ataxia, Friedreich’s ataxia, and optic atrophy[3][4].Associated with neurological disorders, intellectual disability, and degeneration of retinal ganglion cells[3][4].

Beyond the preview

Go deeper on Mitochondrial-processing peptidase subunit alpha (PMPCA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial-processing peptidase subunit alpha (PMPCA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call